Clinical characteristics and oncological outcomes in negative multiparametric MRI patients undergoing robot-assisted radical prostatectomy.

Journal: The Prostate
PMID: 34057211

Abstract

BACKGROUND: Efforts are ongoing to try and find ways to reduce the number of unnecessary prostate biopsies without missing clinically significant prostate cancers (csPCa). The utility of multiparametric magnetic resonance imaging (mpMRI) in detecting prostate cancer (PCa) shows promise to be used as triage test for systematic prostate biopsy. Our aim is to Study clinical parameters and oncological outcomes in men with negative mpMRI (nMRI; PI-RADS v2 scores of ≤ 2) who underwent robot-assisted radical prostatectomy (RARP) to evaluate nMRI's practicality as a biopsy triage test.

Authors

  • Vinayak G Wagaskar
    Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
  • Parita Ratnani
    Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
  • Micah Levy
    Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
  • Kate Moody
    Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
  • Mariely Garcia
    Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
  • Adriana M Pedraza
    Department of Urology, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Sneha Parekh
    Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
  • Krunal Pandav
    Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
  • Bhavya Shukla
    Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
  • Stanislaw Sobotka
    Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
  • Kenneth Haines
    Department of Pathology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
  • Peter Wiklund
    Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Ash Tewari
    Icahn School of Medicine of Mount Sinai, New York, NY, USA.

Keywords

External Resources

Popular Topics
Recent Journals